Cladribine

Lymphopenia: 2 case reports

    This is a preview of subscription content, access via your institution.

    Reference

    1. Margoni M, et al. A multicentre, real-life study on the risk of lymphopenia and infections discloses a favourable safety profile of cladribine in ms patients. Multiple Sclerosis Journal 26 (Suppl.): 252 (plus poster) abstr. P0273, No. 3, Dec 2020. Available from: URL: http://doi.org/10.1177/1352458520974937 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Cladribine. Reactions Weekly 1842, 127 (2021). https://doi.org/10.1007/s40278-021-90863-3

    Download citation